19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...
18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has ...
12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...
1 August 2024 - Medison Pharma, alongside their partner Alnylam Pharmaceuticals, are pleased to announce that from 1 August 2024, ...
2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...
31 July 2024 - The agenda for the November 2024 PBAC meeting is now available. ...
31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...
1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks ...
21 July 2024 - Australia’s medicine subsidy scheme is so crippled that a staggering 10,000 patients a year are being forced ...
19 July 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2024 ...
19 July 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...
19 July 2024 - The outcome statement from the June 2024 DUSC meeting is now available. ...
10 July 2024 - Australian children and young adults with neuroblastoma, a cancer that affects the nervous system, will be ...
10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...